✦ LIBER ✦

Gastrointestinal side effects can reduce compliance with oral bisphosphonate therapy in cancer patients

✍ Scribed by S. Heatley; H. Lothman; P. Major

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PERSISTENCE AND COMPLIANCE (ADHERENCE) W

✍ A. Hoer; H. Gothe; V. Barghout; G. Schiffhorst; B. Hauessler 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Oral bisphosphonates are associated with

✍ H. Gothe; Hoer; V. Barghout; G. Schiffhorst; B. Haeussler 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Oral enzymes preventing side effects of

✍ M.S. Gujral; P.M. Patnaik; R. Kaul; G.V. Daftary; H.K. Parikh; C.P. Tamhankar; W 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 337 KB

Treatment with intravenous pamidronate i

✍ Danielle A Eekman; Marijn Vis; Irene EM Bultink; Harm JGM Derikx; Ben AC Dijkman 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 217 KB

Evidence of interrelated side effects wi

✍ Marcel A. Baltzan; Osama Elkholi; Norman Wolkove 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Management of cutaneous side-effects of

✍ J Ocvirk; S Cencelj 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB